Mechanism-based therapies for pain

被引:9
|
作者
Block, BM [1 ]
Hurley, RW [1 ]
Raja, SN [1 ]
机构
[1] Johns Hopkins Univ, Div Pain Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA
关键词
D O I
10.1358/dnp.2004.17.3.829015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pain is a universal human experience. Usually pain is a normal homeostatic mechanism to force an organism to avoid or reduce injury. As such, the body has many pain messengers, receptors and neural pathways to sense that information. Sensing a stimulus that leads to, or has the potential to cause, tissue injury is termed "nociception." In clinical disease states, pain may be the result of tissue damage or aberrant signal processing. In either case, we may want to interrupt or reduce nociception to produce clinical analgesia. We will discuss the mechanisms of pain sensation, sites and actions of analgesic therapies presently used, and potential avenues for the development of novel pharmaceutical agents to interrupt the sensation and signaling of pain and thus provide pain relief or analgesia. Two other terms are used commonly in the pain literature, hyperalgesia and allodynia. Hyperalgesia is an increase in the magnitude of pain induced by a stimulus that is normally painful. Allodynia is when a usually nonpainful stimulus, like light touch, becomes painful. The review is divided into two parts: Nociceptors and Pain pathways to the brain. The first part discusses nociception at the peripheral nerve ending, while the second discusses the neurotransmission of pain signals to the spinal cord and up to the brain. (C) 2004 Prous Science. All rights reserved.
引用
收藏
页码:172 / 186
页数:15
相关论文
共 50 条
  • [31] Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma
    Natalie J. Miller
    Shailender Bhatia
    Upendra Parvathaneni
    Jayasri G. Iyer
    Paul Nghiem
    Current Treatment Options in Oncology, 2013, 14 : 249 - 263
  • [32] Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma
    Miller, Natalie J.
    Bhatia, Shailender
    Parvathaneni, Upendra
    Iyer, Jayasri G.
    Nghiem, Paul
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 249 - 263
  • [33] Pain in the Blood? Envisioning Mechanism-Based Diagnoses and Biomarkers in Clinical Pain Medicine
    Backryd, Emmanuel
    DIAGNOSTICS, 2015, 5 (01): : 84 - 95
  • [34] Mechanism-based pain diagnosis - Issues for analgesic drug development
    Woolf, CJ
    Max, MB
    ANESTHESIOLOGY, 2001, 95 (01) : 241 - 249
  • [35] Stratification of neuropathic pain patients: the road to mechanism-based therapy?
    Forstenpointner, Julia
    Rehm, Stefanie
    Gierthmuehlen, Janne
    Baron, Ralf
    CURRENT OPINION IN ANESTHESIOLOGY, 2018, 31 (05) : 562 - 568
  • [36] Mechanism-based treatment in chronic neuropathic pain: The role of antidepressants
    Coluzzi, F
    Mattia, C
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (23) : 2945 - 2960
  • [37] Pain in Parkinson's disease: Mechanism-based treatment strategies
    Rukavina, Katarina
    Cummins, Tatum M.
    Chaudhuri, K. Ray
    Bannister, Kirsty
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2021, 15 (02) : 108 - 115
  • [38] Low back pain: Moving toward mechanism-based management
    Mousavi, Seyed Javad
    van Dieen, Jaap H.
    Anderson, Dennis E.
    CLINICAL BIOMECHANICS, 2019, 61 : 190 - 191
  • [39] Mechanism-based therapy for neuropathic pain-a concept in danger?
    Binder, Andreas
    Baron, Ralf
    PAIN, 2015, 156 (11) : 2113 - 2114
  • [40] Assessment of animal pain and mechanism-based strategies for its reversal
    Fleetwood-Walker, Sue
    Sun, Liting
    Jerina, Helen
    Mitchell, Rory
    VETERINARY JOURNAL, 2012, 193 (02): : 305 - 316